Cargando…

Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics

SCARs are rare and life-threatening hypersensitivity reactions. In general, the increased duration of hospital stays and the associated cost burden are common issues, and in the worst-case scenario, they can result in mortality. SCARs are delayed T cell-mediated hypersensitivity reactions. Recovery...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tempark, Therdpong, John, Shobana, Rerknimitr, Pawinee, Satapornpong, Patompong, Sukasem, Chonlaphat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065683/ https://www.ncbi.nlm.nih.gov/pubmed/35517811 http://dx.doi.org/10.3389/fphar.2022.832048

Ejemplares similares

A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
por: Kloypan, Chiraphat, et al.
Publicado: (2021)

Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population
por: Koomdee, Napatrupron, et al.
Publicado: (2017)

The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam
por: Nguyen, Ai-Hoc, et al.
Publicado: (2023)

HLA-B(*)58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand
por: Sukasem, Chonlaphat, et al.
Publicado: (2016)

HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients
por: Satapornpong, Patompong, et al.
Publicado: (2021)

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
por: Patrinos, George P., et al.
Publicado: (2023)

Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis
por: Sukasem, Chonlaphat, et al.
Publicado: (2021)

Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand
por: Tiwattanon, Kanyawan, et al.
Publicado: (2022)

Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients
por: Sukasem, Chonlaphat, et al.
Publicado: (2018)

Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022
por: Sessa, Francesco, et al.
Publicado: (2023)

Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis
por: Biswas, Mohitosh, et al.
Publicado: (2022)

Genetic Diversity of HLA Class I and Class II Alleles in Thai Populations: Contribution to Genotype-Guided Therapeutics
por: Satapornpong, Patompong, et al.
Publicado: (2020)

Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand
por: Koomdee, Napatrupron, et al.
Publicado: (2022)

The Role of In Vitro Detection of Drug-Specific Mediator-Releasing Cells to Diagnose Different Phenotypes of Severe Cutaneous Adverse Reactions
por: Klaewsongkram, Jettanong, et al.
Publicado: (2021)

Pharmacogenomics and adverse drug reactions in children
por: Rieder, Michael J., et al.
Publicado: (2014)

Association of HLA-B*51:01, HLA-B*55:01, CYP2C9*3, and Phenytoin-Induced Cutaneous Adverse Drug Reactions in the South Indian Tamil Population
por: John, Shobana, et al.
Publicado: (2021)

Pharmacogenomics Factors Influencing the Effect of Risperidone on Prolactin Levels in Thai Pediatric Patients With Autism Spectrum Disorder
por: Hongkaew, Yaowaluck, et al.
Publicado: (2021)

Pharmacogenomic Study Reveals New Variants of Drug Metabolizing Enzyme and Transporter Genes Associated with Steady-State Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Thai Autism Spectrum Disorder Patients
por: Medhasi, Sadeep, et al.
Publicado: (2016)

Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis
por: Garelli, Colton J., et al.
Publicado: (2020)

Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021
por: Agúndez, José A. G., et al.
Publicado: (2022)

Hyperuricemia in Children and Adolescents with Autism Spectrum Disorder Treated with Risperidone: The Risk Factors for Metabolic Adverse Effects
por: Vanwong, Natchaya, et al.
Publicado: (2017)

HLA-B*58:01 allele is strongly associated with allopurinol-induced severe cutaneous adverse reactions in a Thai population
por: Jantararoungtong, Thawinee, et al.
Publicado: (2014)

Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation
por: Su, Shih-Chi, et al.
Publicado: (2016)

An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice
por: Wang, Chuang-Wei, et al.
Publicado: (2022)

Genetic Determinants in HLA and Cytochrome P450 Genes in the Risk of Aromatic Antiepileptic-Induced Severe Cutaneous Adverse Reactions
por: Ahmed, Ali Fadhel, et al.
Publicado: (2021)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Sinovac COVID-19 vaccine–induced cutaneous leukocytoclastic vasculitis
por: Bencharattanaphakhi, Rungrot, et al.
Publicado: (2021)

Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms
por: Dao, Ro-Lan, et al.
Publicado: (2015)

Pharmacogenomics of adverse drug reactions
por: Daly, Ann K
Publicado: (2013)

Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies
por: Biswas, Mohitosh, et al.
Publicado: (2022)

Blister fluid as a cellular input for ex vivo diagnostics in drug-induced severe cutaneous adverse reactions improves sensitivity and explores immunopathogenesis
por: Awad, Andrew, et al.
Publicado: (2021)

Genetic Variations and Frequencies of the Two Functional Single Nucleotide Polymorphisms of SLCO1B1 in the Thai Population
por: Na nakorn, Chalitpon, et al.
Publicado: (2020)

Editorial: Pharmacogenomics of Adverse Drug Reactions
por: Siddiqui, Moneeza K., et al.
Publicado: (2022)

Graves’ disease: an uncommon cause of late sequelae following DRESS (drug reaction with eosinophilia and systemic symptoms)
por: Tempark, Therdpong, et al.
Publicado: (2022)

Transient Treatment Response of Platelet-rich Plasma Injection for Temporal Triangular Alopecia: A Case Report with Dermoscopic Examination Follow-up
por: Lueangarun, Suparuj, et al.
Publicado: (2020)

Pili Trianguli et Canaliculi: A Case Report with 10-year Follow-Up
por: Lueangarun, Suparuj, et al.
Publicado: (2022)

Deciphering the role of autophagy in the immunopathogenesis of inflammatory bowel disease
por: Li, Yue, et al.
Publicado: (2022)

Effects of polymorphisms in the MTHFR gene on 5-FU hematological toxicity and efficacy in Thai colorectal cancer patients
por: Atasilp, Chalirmporn, et al.
Publicado: (2022)

Comparison between the HLA-B(∗)58 : 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions
por: Saksit, Niwat, et al.
Publicado: (2017)

A pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HIV-infected Thai patients: a pilot study
por: Damronglerd, Pansachee, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fan1871iefk01lgr8t0j96tkkq